Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
CancerVax vaccine (CANVAXIN)
BIOLOGICAL
2 trials
Sponsors
CancerVax Corporation
Conditions
Malignant Melanoma
Phase 3
Vaccine Therapy for Patients With Stage IV Melanoma
NCT00052156
CancerVax Corporation
Malignant Melanoma
Target: 670
Updated: 2005-06-24
Vaccine Therapy for Patients With Stage III Melanoma
NCT00052130
CancerVax Corporation
Malignant Melanoma
Target: 1118
Updated: 2005-06-24
Related Papers
Long-Term Survival after Complete Surgical Resection and Adjuvant Immunotherapy for Distant Melanoma Metastases.
2017-10-10
98 citations